AVITA Medical RCEL Insider Ownership

NASDAQ RCEL

$15.29 +1.49 (+10.80%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

1.31Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

2.68%

■0% pp QoQ

Shares Held by Insiders

829.93K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

30.93Mn

30,926,847 shares

Direct Holdings

829.93K

Indirect: 0

Net Shares Traded (QoQ)

no net change in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

In the last 12 months, insiders at Avita Medical made open-market purchases of $234,580 (56K shares) and sold no shares on the open market.

Counted by insider, open-market buying of RCEL stock in the past 12 months came from 2 insiders, with no insider selling.
Among Avita Medical insiders, Joseph Fralin Woody (Director) led open-market buying over the past 12 months with $188,586 of purchases (45.2K shares); the latest was on June 9, 2026.
The latest open-market trade in RCEL stock by an insider was a purchase of 2K shares for $7,940 by David D. O'Toole (CFO) on June 12, 2026.
Beyond open-market trades, insiders at Avita Medical received 273.62K shares in stock awards in the last 12 months.
According to Business Quant data, insiders at Avita Medical reported 829.93K shares in total in their latest Form 4 filings, unchanged from 829.93K shares at the end of Q2 2026 and up 104.45% from 405.94K shares at the end of Q3 2025.
RCEL's insiders hold all 829.93K shares directly, in their own names, with no indirect holdings.
Business Quant counts 11 insiders with holdings in Avita Medical stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
RCEL's three largest insider shareholders, per their latest Form 4 filings, are David D. O'Toole (CFO, 152.93K shares), Robert McNamara (Director, 108.98K shares) and Joseph Fralin Woody (Director, 107.96K shares).
David D. O'Toole alone accounts for 18.43% of the shares held by Avita Medical insiders.
Institutions owned 15.94% of RCEL shares as of Q2 2026; insiders' latest Form 4 filings account for about 2.68%, leaving roughly 81.38% with other investors, including the public.
Over the trailing 12 months, 9 insiders reported transactions in RCEL stock across 20 Form 4 filings.
This summary of Avita Medical insider activity covers Form 4 filings through August 24, 2026.

Form 4 Holdings

Insiders Holding RCEL

Insiders 17

Shares held 1.31Mn

Of outstanding 4.24%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Michael S Perry	Chief Executive Officer	229,543	229,543	17.5%	22 Nov, 2022
2	David D O'Toole	Cfo	152,927	152,927	11.7%	24 Aug, 2026
3	Robert Mcnamara	Director	108,985	108,985	8.3%	04 Jun, 2026
4	Joseph Fralin Woody	Director	107,961	107,961	8.2%	11 Jun, 2026
5	Nicole Kelsey	Chief Legal Officer	98,390	98,390	7.5%	19 Feb, 2026
6	Jeremy Curnock Cook	Director	82,664	82,664	6.3%	04 Jun, 2026
7	Jan Stern Reed	Director	73,225	73,225	5.6%	04 Jun, 2026
8	Suzanne Crowe	Director	69,148	69,148	5.3%	04 Jun, 2026
9	Lou Panaccio	Director	56,428	56,428	4.3%	05 Jun, 2025
10	Michael E Tarnoff	Director	48,464	48,464	3.7%	04 Jun, 2026
11	Kathy M. Mcgee	Chief Operating Officer	46,450	46,450	3.5%	06 Jul, 2022
12	Michael Holder	Chief Financial Officer	46,450	46,450	3.5%	06 Jul, 2022
13	Erin Liberto	Chief Commercial Officer	46,450	46,450	3.5%	06 Jul, 2022
14	Andrew Quick	Chief Technology Officer	46,450	46,450	3.5%	06 Jul, 2022
15	Donna Shiroma	General Counsel	45,951	45,951	3.5%	03 Jun, 2024
16	Cary Guy Vance	President And Ceo	40,771	40,771	3.1%	01 Jun, 2026
17	James Corbett	Ceo	11,580	11,580	0.9%	27 Dec, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

203 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
12 Jun, 2026	David D O'Toole	Cfo	Acquired P	2,000	$3.97	$7.94K	152,927	Direct
12 Jun, 2026	David D O'Toole	Cfo	Acquired A	2,000	$3.97	$7.94K	152,927	Direct
09 Jun, 2026	Joseph Fralin Woody	Director	Acquired P	5,200	$4.00	$20.80K	107,961	Direct
09 Jun, 2026	Joseph Fralin Woody	Director	Acquired P	5,000	$4.20	$21.00K	97,761	Direct
09 Jun, 2026	Joseph Fralin Woody	Director	Acquired P	5,000	$4.18	$20.90K	102,761	Direct
03 Jun, 2026	Joseph Fralin Woody	Director	Acquired P	5,000	$4.10	$20.50K	87,761	Direct
03 Jun, 2026	Joseph Fralin Woody	Director	Acquired P	5,000	$4.09	$20.45K	92,761	Direct
20 Jan, 2026	Jeremy Curnock Cook	Director	Acquired A	22,214	—	—	62,050	Direct
20 Jan, 2026	Jan Stern Reed	Director	Acquired A	22,214	—	—	73,225	Direct
05 Jan, 2026	Joseph Fralin Woody	Director	Acquired A	40,547	—	—	60,547	Direct
20 Jan, 2026	Robert Mcnamara	Director	Acquired A	22,214	—	—	108,985	Direct
06 Aug, 2025	Michael E Tarnoff	Director	Acquired A	26,250	—	—	26,250	Direct
20 Jan, 2026	Suzanne Crowe	Director	Acquired A	22,214	—	—	69,148	Direct
20 Jan, 2026	Jeremy Curnock Cook	Director	Acquired A	16,133	$0.00	$0	16,133	Direct
20 Jan, 2026	Jan Stern Reed	Director	Acquired A	16,133	$0.00	$0	16,133	Direct
20 Jan, 2026	Joseph Fralin Woody	Director	Acquired A	22,214	—	—	82,761	Direct
20 Jan, 2026	Robert Mcnamara	Director	Acquired A	16,133	$0.00	$0	16,133	Direct
20 Jan, 2026	Michael E Tarnoff	Director	Acquired A	22,214	—	—	48,464	Direct
20 Jan, 2026	Suzanne Crowe	Director	Acquired A	16,133	$0.00	$0	16,133	Direct
05 Jan, 2026	Joseph Fralin Woody	Director	Acquired A	29,446	$0.00	$0	29,446	Direct

Showing 1 to 20 of 203 transactions